论文部分内容阅读
目的观察标准化屋尘螨疫苗安脱达治疗儿童过敏性支气管哮喘的疗效和安全性。方法以2007年1月至2011年3月在哈尔滨市儿童医院变态反应科门诊治疗的屋尘螨过敏性哮喘患儿40例为治疗组,给予安脱达标准化屋尘螨疫苗脱敏治疗;以另40例儿童过敏性支气管哮喘同时伴屋尘螨过敏且不愿接受免疫治疗者作为对照组,仅同时进行哮喘的一般治疗,比较两组疗效。结果治疗组临床控制28例,显效8例,有效3例,无效1例,总有效率97.5%(39/40)。对照组临床控制19例,显效9例,有效7例,无效5例,总有效率87.5%(35/40)。两组总有效率比较,差异有统计学意义(P<0.05)。结论安脱达标准化屋尘螨疫苗治疗儿童屋尘螨过敏性支气管哮喘有明显效果。
Objective To observe the efficacy and safety of standard house dust mite vaccine, adetida in children with allergic bronchial asthma. Methods Forty patients with house dust mite allergic asthma treated in Department of Allergy of Harbin Children’s Hospital from January 2007 to March 2011 were treated with detemination treatment of standard house dust mite vaccine. Another 40 children with allergic bronchial asthma with house dust mite allergy and unwilling to receive immunotherapy as a control group, only the same time the general treatment of asthma, the efficacy of the two groups were compared. Results In the treatment group, 28 cases were clinically controlled, 8 cases were markedly effective, 3 cases were effective and 1 case was ineffective. The total effective rate was 97.5% (39/40). The control group, 19 cases of clinical control, markedly effective in 9 cases, effective in 7 cases, 5 cases, the total effective rate was 87.5% (35/40). The total effective rate between the two groups, the difference was statistically significant (P <0.05). Conclusions The standard of house-dust mite anti-infectives of Amiodar for the treatment of allergic bronchial asthma in house dust mites has significant effect.